Well .... over the past 3 weeks I have slowly sold down all my CYP holdings for a small profit of circa $25K .... whilst there have been a couple of positive updates from the company in recent times, realistically CYP has a long way to go.
GVHD trial readouts are at least 18 months off.... DFU is at least 6 months off .... OA trial data at least 24 months off etc - the 'solid cash position' of $11.1 million (probably now ~$9 million) won't last regardless of what some on here claim so I envisage a CR by 30 June 2024 as I have said a number of times (eg. Post #:70795480 Post #:70558972 ) if the options aren't exercised / reach strike price - international trials cost money and although the OA trial is funded by the National Health and Medical Research Council (NHMRC) GVHD certainly isn't and of course they need to keep the lights on and pay wages ....
Sure a partnership deal might present itself or a takeover but hey that's the risks one takes in the share market
GLTAH
CYP Price at posting:
19.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
of $11.1 million (probably now ~$9 million) won't last regardless of what some on here claim so I envisage a CR by 30 June 2024 as I have said a number of times (eg. Post #:70795480 Post #:70558972 ) if the options aren't exercised / reach strike price - international trials cost money and although the OA trial is funded by the National Health and Medical Research Council (NHMRC) GVHD certainly isn't and of course they need to keep the lights on and pay wages ....
(20min delay)